J&J pauses COVID vaccine trial following unexplained illness of participants

DY365
DY365
Published: October 13,2020 08:31 AM
DY365

Story highlights

October 13, 2020: Johnson & Johnson said its Covid-19 vaccine study has been temporarily halted due to an unexplained illness in a trial participant.

October 13, 2020: Johnson & Johnson said its Covid-19 vaccine study has been temporarily halted due to an unexplained illness in a trial participant.



Jake Sargent, a spokesman for the New Brunswick, New Jersey Company, confirmed an earlier report by health-care news provider STAT that the study was paused.



Earlier this month, Johnson & Johnson joined the short list of vaccine makers that have moved an experimental coronavirus shot into late-stage human studies in the U.S. The company has since begun dosing up to 60,000 volunteers, marking the first big trial of a Covid-19 inoculation that may work after just one shot.



News of the halt comes after AstraZeneca Plc temporarily stopped tests of its vaccine after a trial participant fell ill. That study has resumed in a number of countries but remains halted in the U.S.